Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Indian Journal of Experimental Biology|November 16, 2013
In vitro cytotoxicity testing of new generation oxazaphosphorines against human histiocytic lymphoma cellsMałgorzata Opydo-Chanek, Lidia Mazur, Marta Stojak
Anti-Cancer Drugs|March 24, 2011
Glufosfamide as a new oxazaphosphorine anticancer agentLidia Mazur, Małgorzata Opydo-Chanek, Marta Stojak
Biochemical Pharmacology|March 2, 2020
The endothelial barrier and cancer metastasis: Does the protective facet of platelet function matter?Marta Smeda, Kamil Przyborowski, Marta Stojak, et al.
Anticancer Research|July 4, 2012
Mafosfamide as a new anticancer agent: preclinical investigations and clinical trialsLidia Mazur, Malgorzata Opydo-Chanek, Marta Stojak, et al.
Folia Biologica|June 18, 2013
In vitro effects of new generation oxazaphosphorines on human promyelocytic leukemia cellsLidia Mazur, Małgorzata Opydo-Chanek, Marta Stojak, et al.
Cellular and Molecular Life Sciences : CMLS|December 8, 2020
Astaxanthin as a new Raman probe for biosensing of specific subcellular lipidic structures: can we detect lipids in cells under resonance conditions?Krzysztof Czamara, Adriana Adamczyk, Marta Stojak, et al.
Folia Biologica|March 21, 2012
Comparative effects of new generation oxazaphosphorines on the size and viability of human acute myeloblastic leukemia cellsLidia Mazur, Małgorzata Opydo-Chanek, Katarzyna Wojcieszek, et al.
Anticancer Research|December 16, 2014
Cell-cycle disturbance and induction of programmed death by new formamidine analogs of daunorubicinMarta Stojak, Małgorzata Lukawska, Irena Oszczapowicz, et al.
Folia Biologica|April 28, 2010
Induction of DNA breakage in U937 cells by oxazaphosphorinesLidia Mazur, Małgorzata Opydo-Chanek, Marta Stojak, et al.
Pageof 5